A close look at human IgG sialylation and subclass distribution after lectin fractionation

Proteomics

Volumn 9, Issue 17, 2009, Pages 4143-4153

  Stadlmann, Johannes ^a   Weber, Alfred ^b   Pabst, Martin ^a   Anderle, Heinz ^b   Kunert, Renate ^a   Ehrlich, Hartmut J ^b   Schwarz, Hans Peter ^b   Friedrich, Altmann ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b BAXTER BIOSCIENCE   (Austria)

Author keywords

Antibody; Glycoprotein; Glycoproteomics; IgG; Lectin

Indexed keywords

AGGLUTININ; GLYCOPEPTIDASE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; LECTIN; MONOCLONAL ANTIBODY;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CHROMATOGRAPHY; CONTROLLED STUDY; FRACTIONATION; GLYCOSYLATION; HUMAN; HYPOTHESIS; MASS SPECTROMETRY; PRIORITY JOURNAL; SAMBUCUS NIGRA; SIALYLATION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CHEMICAL FRACTIONATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; MASS SPECTROMETRY; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; PLANT LECTINS; RIBOSOME INACTIVATING PROTEINS; SEPHAROSE; SIALIC ACIDS;

MURINAE; SAMBUCUS NIGRA;

EID: 69949107840     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800931     Document Type: Article

References (38)

1. Jefferis, R., Antibody therapeutics: isotype and glycoform selection. Expert Opin. Biol. Ther. 2007, 7, 1401-1413. (Pubitemid 47475656)
2. Nechansky, A., Schuster, M., Jost, W., Siegl, P. et al., Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodies. Mol. Immunol. 2007, 44, 1815-1817.
3. Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E. et al., The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 2003, 278, 3466-3473. (Pubitemid 36801263)
4. Stadlmann, J., Pabst, M., Kolarich, D., Kunert, R. et al., Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 2008, 8, 2858-2871.
5. Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L. et al., Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985, 316, 452-457.
6. Shinzaki, S., Iijima, H., Nakagawa, T., Egawa, S. et al., IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Am. J. Gastroenterol. 2008, 103, 1173-1181. (Pubitemid 351677959)
7. Tomana, M., Schrohenloher, R. E., Koopman, W. J., Alarcon, G. S. et al., Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum. 1988, 31, 333-338. (Pubitemid 18091655)
8. Holland, M., Yagi, H., Takahashi, N., Kato, K. et al., Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim. Biophys. Acta 2006, 1760, 669-677.
9. Wuhrer, M., Stam, J. C., van de Geijn, F. E., Koeleman, C. A. et al., Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 2007, 7, 4070-4081. (Pubitemid 350190279)
10. Jefferis, R., Glycosylation of recombinant antibody therapeutics. Biotechnol. Prog. 2005, 21, 11-16.
11. Abel, C. A., Spiegelberg, H. L., Grey, H. M., The carbohydrate contents of fragments and polypeptide chains of human gamma-G-myeloma proteins of different heavychain subclasses. Biochemistry 1968, 7, 1271-1278.
12. Imbach, P., Barandun, S., d'Apuzzo, V., Baumgartner, C. et al., High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981, 1, 1228-1231.
13. Kazatchkine, M. D., Kaveri, S. V., Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 2001, 345, 747-755. (Pubitemid 34936657)
14. Negi, V. S., Elluru, S., Siberil, S., Graff-Dubois, S. et al., Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J. Clin. Immunol. 2007, 27, 233-245. (Pubitemid 46790823)
15. Vani, J., Elluru, S., Negi, V. S., Lacroix-Desmazes, S. et al., Role of natural antibodies in immune homeostasis: IVIg perspective. Autoimmun. Rev. 2008, 7, 440-444.
16. Tha-In, T., Bayry, J., Metselaar, H. J., Kaveri, S. V. et al., Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol. 2008, 29, 608-615.
17. Nimmerjahn, F., Ravetch, J. V., Anti-inflammatory actions of intravenous immunoglobulin. Annu. Rev. Immunol. 2008, 26, 513-533.
18. Kaneko, Y., Nimmerjahn, F., Ravetch, J. V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006, 313, 670-673. (Pubitemid 44201145)
19. Shibuya, N., Goldstein, I. J., Broekaert, W. F., Nsimba- Lubaki, M. et al., The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J. Biol. Chem. 1987, 262, 1596-1601.
20. Anthony, R. M., Wermeling, F., Karlsson, M. C., Ravetch, J. V., Identification of a receptor required for the antiinflammatory activity of IVIG. Proc. Natl. Acad. Sci. USA 2008, 105, 19571-19578.
21. Guo, Y., Feinberg, H., Conroy, E., Mitchell, D. A. et al., Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 2004, 11, 591-598. (Pubitemid 38823524)
22. Erntell, M., Myhre, E. B., Sjobring, U., Bjorck, L., Streptococcal protein G has affinity for both Fab- and Fc-fragments of human IgG. Mol. Immunol. 1988, 25, 121-126. (Pubitemid 18197487)
23. Pabst, M., Bondili, J. S., Stadlmann, J., Mach, L. et al., Mass1retention time5structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal. Chem. 2007, 79, 5051-5057. (Pubitemid 47051461)
24. Itoh, Y., Ichihara, K., Kanno, T., Sugawara, T. et al., Serum protein standardization project in Japan: evaluation of an IFCC reference material (RPPHS/CRM470) and establishment of reference intervals. J. Clin. Lab. Anal. 1997, 11, 39-44. (Pubitemid 27053387)
25. Dati, F., Schumann, G., Thomas, L., Aguzzi, F. et al., Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur. J. Clin. Chem. Clin. Biochem. 1996, 34, 517-520.
26. Olson, B. J., Markwell, J., Assays for determination of protein concentration. Curr. Protoc. Protein Sci. 2007, Chapter 3, Unit 3.4.
27. Resch, K., Imm, W., Ferber, E., Wallach, D. F. et al., Quantitative determination of soluble and membrane proteins through their native fluorescence. Naturwissenschaften 1971, 58, 220.
28. Altmann, F., Determination of amino sugars and amino acids in glycoconjugates using precolumn derivatization with o-phthalaldehyde. Anal. Biochem. 1992, 204, 215-219.
29. Kolarich, D., Weber, A., Turecek, P. L., Schwarz, H. P. et al., Comprehensive glyco-proteomic analysis of human alpha1- antitrypsin and its charge isoforms. Proteomics 2006, 6, 3369-3380. (Pubitemid 43886153)
30. Kunert, R., Wolbank, S., Stiegler, G., Weik, R. et al., Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody. AIDS Res. Hum. Retroviruses 2004, 20, 755-762. (Pubitemid 39037507)
31. Masuda, K., Yamaguchi, Y., Kato, K., Takahashi, N. et al., Pairing of oligosaccharides in the Fc region of immunoglobulin G. FEBS Lett. 2000, 473, 349-357.
32. Krapp, S., Mimura, Y., Jefferis, R., Huber, R. et al., Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 2003, 325, 979-989. (Pubitemid 36263407)
33. Wormald, M. R., Rudd, P. M., Harvey, D. J., Chang, S. C. et al., Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 1997, 36, 1370-1380.
34. Jefferis, R., Reimer, C. B., Skvaril, F., de Lange, G. G. et al., Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the 2nd IUIS/WHO collaborative study. Immunol. Lett. 1992, 31, 143-168.
35. Schauer, U., Stemberg, F., Rieger, C. H., Borte, M. et al., IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin. Chem. 2003, 49, 1924-1929. (Pubitemid 37340328)
36. Dalziel, M., McFarlane, I., Axford, J. S., Lectin analysis of human immunoglobulin G N-glycan sialylation. Glycoconj. J. 1999, 16, 801-807.
37. Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N. et al., Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008, 320, 373-376. (Pubitemid 351555659)
38. Nimmerjahn, F., Ravetch, J. V., Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 2005, 310, 1510-1512. (Pubitemid 41746349)